Keywords: merck, co, sales, grow, 2nd, qtr, eps
Merck & Co sales grow 8% in 2nd qtr, EPS falls slightly to $0.77
Article | 29 July 2002
Drug giant Merck & Co has posted net income of $1.75 billion forsecond-quarter 2002, a decrease of 3.8% on the like, year-earlier period. Sales ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
